Comment about "Hypertonic saline solution for modifying tissue ischemia/reperfusion injury: Porcine aortic occlusion model"

1. Escobar B, Guevara-Cruz OA, Navarro-Vargas JR, et al. Hypertonic saline solution for modifying tissue ischemia/reperfusion injury: Porcine aortic occlusion model. Rev Colomb Anestesiol 2017; 45:280-290.
2. Heino A, Hartikainen J, Merasto ME, et al. Effects of dobuta-mine on splanchnic tissue perfusion during partial superior mesenteric artery occlusion. Crit Care Med 2000;28:3484-3490.
3. Sidi A, Muehlschlegel JD, Kirby DS, et al. Treating ischemic left ventricular dysfunction with hypertonic saline administered after coronary occlusion in pigs. J Cardiothorac Vasc Anesth 2007; 21:400-405.
4. Mouren S, Delayance S, Mion G, et al. Mechanisms of increased myocardial contractility with hypertonic saline solutions in isolated blood-perfused rabbit hearts. Anesth Analg 1995;81: 777-782.
5. Huerta L, Rancan L, Simón C, et al. Ischaemic preconditioning prevents the liver inflammatory response to lung ischaemia/ reperfusion in a swine lung autotransplant model. Eur J Cardiothorac Surg 2013;43:1194-1201.
6. Li R, Zijlstra JG, Kamps JAAM, et al. Abrupt reflow enhances cytokine- induced proinflammatory activation of endothelial cells during simulated shock and resuscitation. Shock 2014; 42:356-364.
7. Lomivorotov VV, Fominskiy EV, Efremov SM, et al. Hypertonic solution decreases extravascular lung water in cardiac patients undergoing cardiopulmonary bypass surgery. J Cardiothorac Vasc Anesth 2013;27:273-282.
8. Oliveira-santos M, Lopes MF, Catré D, et al. Efeito de hidrox-ietilamido sobre lesão renal aguda em modelo de isquemia-reperfusão hepática. Acta Med Port 2012;25:308-316.
9. Nikolian VC, Pan B, Mesar T, et al. Lung protective effects of low-volume resuscitation and pharmacologic treatment of swine subjected to polytrauma and hemorrhagic shock. Inflammation 2017;40:1264-1274.
10. Rallis D, Poulos P, Kazantzi M, et al. Effectiveness of 7.5% hypertonic saline in children with severe traumatic brain injury. J Crit Care 2017;38:52-56.
11. Opie LH. Point of view reperfusion injury and its pharmacologic modification. Circulation 1989;80:1049-1062.
12. Shaw AD, Munson SH, Paluszkiewicz SM, et al. Association between intravenous chloride load during resuscitation and inhospital mortality among patients with SIRS. Intensive Care Med 2014;40:1897-1905.
13. Boniatti M, Cardoso P, Castilho R, et al. Is hyperchloremia associated with mortality in critically ill patients? A prospective cohort study. J Crit Care 2011;26:175-179.
14. Lindner G, Funk GC, Schwarz C, et al. Hypernatremia in the critically ill is an independent risk factor for mortality. Am J Kidney Dis 2007;50:952-957.
15. Myburgh JA, Mythen MG. Resuscitation fluids. N Engl J Med 2013;369:1243-1251.
16. Perners A, Haase N, Guttormsen AB, et al. Hydroxyethyl starch 130/0.42 versus ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-134.
17. Cooper D, Myburgh J, Heritier S, et al. Albumin resuscitation for traumatic brain injury: is intracranial hypertension the cause of increased mortality? J Neurotrauma 2013;30:512-518.
18. Wang N, Jiang L, Zhu B, et al. Fluid balance and mortality in critically ill patients with acute kidney injury: a multicenter prospective epidemiological study. Crit Care 2015;19:1-11.
19. Semler MW, Self WH, Wang L, et al. Balanced crystalloids versus saline in the intensive care unit: study protocol for a cluster-randomized, multiple-crossover trial. Trials 2017;18:1-13.
20. Prieto I, Monsalve M. Redox Biology ROS homeostasis, a key determinant in liver ischemic-preconditioning. Redox Biol 2017;12:1020-1025.
21. Shields CJ, Winter DC, Manning BJ, et al. Hypertonic saline infusion for pulmonary injury due to ischemia-reperfusion. Arch Surg 2003;138:9-14.
22. Azoubel G, Nascimento IB, Ferri IIM, et al. Operating room use of hypertonic solutions: a clinical review. Clinics 2008;63:833-840.